Mirus Bio at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Mirus Bio brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on transfection chemistry for large-scale vector production. Both topics stabilise the transfection complex, one to make lentiviral material for in vivo use, the other to give AAV manufacturing more flexibility at scale.

OrganizationESGCT 2026 Attendance
Mirus Bio
Madison, WI
mirusbio.com
Tools & reagents
Makes transfection reagents used to produce AAV and lentiviral vectors at scale; part of Merck's life science business.
Poster
Wed Oct 28
1:30pm–3:30pm
Enabeling scalable lentiviral manufacturing for in vivo use through transfection complex stabilization
Manufacturing
Poster
Thu Oct 29
2:00pm–4:00pm
Stabilize to scale: advancing flexible large-scale AAV manufacturing with a novel transfection complex stabilizer
Manufacturing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Mirus Bio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction